Famotidine For Suspension
Product Images NDC 43598-572

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 43598-572). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Fam09 0001 01)

Structural Formula (Fam09 0001 01)
Chemical structure diagram of the active ingredient famotidine, showing its molecular composition and key functional groups.*
FDA Label Image

Principal Display Panel – 50 mL Bottle Label (Fam09 0001 02)

Principal Display Panel – 50 mL Bottle Label (Fam09 0001 02)
Famotidine for Oral Suspension, USP 40 mg/5 mL label from Dr. Reddy's Laboratories Inc. The label states the suspension contains 400 mg total famotidine in 50 mL, with each 5 mL dose providing 40 mg famotidine. It instructs shaking well before use and notes the bottle is oversized for shaking. Storage and preparation directions, barcode, and manufacturer details are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.